Pfeiffenberger Brent's most recent trade in Century Therapeutics Inc was a trade of 1,587,614 Common Stock done . Disclosure was reported to the exchange on Aug. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 1,587,614 | 3,269,397 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 09 Jun 2025 | 475 | 1,681,783 | - | 0.6 | 295 | Common Stock |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 16 May 2025 | 29,552 | 1,682,258 | - | 0.5 | 16,135 | Common Stock |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 521,500 | 1,711,810 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 521,500 | 521,500 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 10 Mar 2025 | 2,235 | 1,190,310 | - | 0.6 | 1,375 | Common Stock |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 18 Feb 2025 | 34,712 | 1,192,545 | - | 0.8 | 27,179 | Common Stock |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.44 per share. | 04 Dec 2024 | 243,447 | 1,227,257 | - | 1.4 | 350,564 | Common Stock |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 104,550 | 104,550 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 17,425 | 1,470,704 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Pfeiffenberger Brent | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 1,173,775 | 1,173,775 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 573,691 | 573,691 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 279,504 | 1,453,279 | - | 0 | Common Stock |